Results 141 to 150 of about 21,331 (238)

Cardiovascular Toxicities of BTK Inhibitors in Chronic Lymphocytic Leukemia: JACC: CardioOncology State-of-the-Art Review. [PDF]

JACC CardioOncol, 2023
Quartermaine C, Ghazi SM, Yasin A, Awan FT, Fradley M, Wiczer T, Kalathoor S, Ferdousi M, Krishan S, Habib A, Shaaban A, Kola-Kehinde O, Kittai AS, Rogers KA, Grever M, Ruz P, Bhat S, Dickerson T, Byrd JC, Woyach J, Addison D.   +20 more
europepmc   +1 more source

BTK Inhibitor LOXO-305 [PDF]

, 2020
openaire   +1 more source

Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors. [PDF]

Cancers (Basel)
Robak E, Robak T.
europepmc   +1 more source

Efficacy and safety of BTK inhibitors in Richter's transformation: a systematic review of clinical evidence. [PDF]

Front Oncol
Dirican CD, Ajayi F, Al Mardini A, Crocete Aloysia Fernandes B, Sofia A, Gondhi V, Shaaban H, Maroules M.   +7 more
europepmc   +1 more source

Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities. [PDF]

Cancers (Basel), 2023
Frustaci AM, Deodato M, Zamprogna G, Cairoli R, Montillo M, Tedeschi A.   +5 more
europepmc   +1 more source

Cardiac safety profiles of first-generation vs second-generation BTK inhibitors: a meta-analysis. [PDF]

Oncologist
Mushtaq A, Ahmed EN, Aljumaa R, E'mar AR, Badwan O, Ashruf O, Elshaer A, Shaik A, Baroudi M, Moudgil R, Mustafa Ali MK.   +10 more
europepmc   +1 more source

Novel therapies and combinations in CLL refractory to BTK inhibitors and venetoclax. [PDF]

Hematology Am Soc Hematol Educ Program, 2022
Scarfò L.
europepmc   +1 more source

Move along, nothing to see here: Btk inhibitors stop platelets sticking to plaques [PDF]

, 2018
Busygina, Bye, Bye, Byrd, Jamasbi, Levade   +5 more
core   +1 more source

Systemic high-dose MTX and BTK inhibitors in vitreoretinal lymphoma: efficacy and survival analysis. [PDF]

Blood Sci
Gao J, Lv LW, Zhou SW, Yao N, Yang L, Ye J, Zhang L, Peng X, Wang L.   +8 more
europepmc   +1 more source

BTK Inhibitor CT-1530 [PDF]

, 2020
openaire   +1 more source